Download Now

Your Token Count	0
Product Token Price	24

Sign in to Purchase/Download Documents

Sign in / Register

User login

Social Networking

Support Free Media

Tamoxifen

Tamoxifen

User Options

A Membership is required. Please Login or Create an account to get started

Purchase the Exhaustive Downloadable Document on this Topic

Make a Request for GMI to add more Articles on this Topic Immediately (Purchase Required)

View a Printer Friendly version of this page

E-mail this page to a friend

Perform a Search with this Topic

Hover over an icon for more information

Additional Topics Details for this Page

Article Count - 39
Cumulative Knowledge - 319

Advanced Database Options

Limit Articles Displayed by the Following Study Types

Available Sorting Options

Limited to Members Only

By default, all articles on GreenMedInfo.com are sorted based on the content type which best reflects the data which most users are searching for. For instance, people viewing substances are generally most interested in viewing diseases that these substances have shown to have positive influences. This section is for allowing more advanced sorting methods. Currently, these advanced sorting methods are available for members only. If you are already a member, you can sign in by clicking here. If you do not currently have a user account, and would like to create one/become a member, click here to begin the singup process.

Currently Available Sorting Options

Article Published Date - Sort all displayed articles by their published date
Quick Summary Fieldsets - Sort alphabetically, rather than by Cumulative Knowledge
Cumulative Knowledge - Default sorting method. Allows you to sort descendingly

What is Cumulative Knowledge?

Cumulative Knowledge is determined by ascribing a numerical value to the various study types weighted in descending order as follows: (1) Meta-Analysis; (2) Human Study; (3) Human: Case Study; (4) Animal: Transgenic; (5) Animal; (6) In Vitro; (7) Review; and (8) Commentary.

Click here for a more thorough explanation.

Quick Summary: Current access displays 2 out of 29 associated Diseases

Name	Cumulative Knowledge	Article Count	Focus Articles
Endometrial Cancer	116	15	Log in \| Sign up
Breast Cancer	93	11	Log in \| Sign up

Quick Summary: Current access displays 2 out of 13 associated Adverse Pharmacological Actions

Name	Cumulative Knowledge	Article Count	Focus Articles
Carcinogenic	110	16	Log in \| Sign up
Neurotoxic	40	3	Log in \| Sign up

Currently Viewing Free Sample of Member Only Features

Although all 19,000+ articles on GreenMedInfo.com are made entirely free to view as an educational service to the public, we provide a powerful set of enhanced data comprehension and retrieval tools for subscribing members. Above you are viewing a free preview, limited to 2 rows, of the membership feature called "Cumulative Knowledge" (learn more).

The Focus Article Feature is not enabled.

Upgrading to the Member role gives you access to unlimited rows of Cumulative Knowledge data.

To Participate

Click here to login
Click here to create an account

View the Evidence: Problem Substances

Five or more years of tamoxifen use increases risk of cataracts in breast cancer patients.

Click here to read the entire abstract

Pubmed Data : Breast Cancer Res Treat. 2000 Mar;60(2):167-72. PMID: 10845279

Article Published Date : Mar 01, 2000

Study Type : Meta Analysis

Additional Links

Diseases : Cataract : CK(182) : AC(55), Drug-Induced Toxicity : CK(560) : AC(78)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Postoperative tamoxifen for ductal carcinoma in situ does not reduce overall mortality.

Click here to read the entire abstract

Pubmed Data : Cochrane Database Syst Rev. 2012 ;10:CD007847. Epub 2012 Oct 17. PMID: 23076938

Article Published Date : Dec 31, 2011

Study Type : Meta Analysis

Additional Links

Diseases : Breast Cancer : CK(2361) : AC(621)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Tamoxifen interferes with cognitive function in breast cancer patients.

Click here to read the entire abstract

Pubmed Data : Breast Cancer Res Treat. 2000 Nov;64(2):165-76. PMID: 11194452

Article Published Date : Nov 01, 2000

Study Type : Meta Analysis

Additional Links

Diseases : Cognitive Decline/Dysfunction : CK(522) : AC(87), Drug-Induced Toxicity : CK(560) : AC(78), Memory Disorders: Drug-Induced : CK(77) : AC(12)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Neurotoxic : CK(1076) : AC(179)

Tamoxifen use may cause endometrial cancer, as well as being associated with poorer prognosis.

Click here to read the entire abstract

Pubmed Data : Int J Cancer. 1998 May 4;76(3):325-30. PMID: 9579567

Article Published Date : May 04, 1998

Study Type : Meta Analysis

Additional Links

Diseases : Endometrial Cancer : CK(269) : AC(45)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Carcinogenic : CK(912) : AC(117)

Two year treatment with Tamoxifen and Arimidex result in a number of side effects which reduce quality of life.

Click here to read the entire abstract

Pubmed Data : Breast Cancer Res Treat. 2006 Dec;100(3):273-84. Epub 2006 Jun 21. PMID: 16944295

Article Published Date : Dec 01, 2006

Study Type : Meta Analysis

Additional Links

Diseases : Drug-Induced Toxicity : CK(560) : AC(78)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Arimidex : CK(122) : AC(12), Tamoxifen : CK(319) : AC(39)

Adjuvant tamoxifen therapy for early stage breast cancer increases the risk of second primarly malignancies such as endometrial, colon and somatch cancer.

Click here to read the entire abstract

Pubmed Data : J Natl Cancer Inst. 1995 May 3;87(9):645-51. PMID: 7752269

Article Published Date : May 03, 1995

Study Type : Human Study

Additional Links

Diseases : Breast Cancer : CK(2361) : AC(621), Colorectal Cancer : CK(877) : AC(321), Endometrial Cancer : CK(269) : AC(45), Gastric Cancer : CK(373) : AC(111)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Carcinogenic : CK(912) : AC(117)

Memory deficits occur in breast cancer patients who receive either chemotherapy or tamoxifen.

Click here to read the entire abstract

Pubmed Data : J Psychosoc Oncol. 2011 Sep-Oct;29(5):499-514. PMID: 21882931

Article Published Date : Sep 01, 2011

Study Type : Human Study

Additional Links

Diseases : Chemotherapy-Induced Toxicity : CK(704) : AC(184), Memory Disorders: Drug-Induced : CK(77) : AC(12), Memory Loss : CK(113) : AC(32)

Anti Therapeutic Actions : Chemotherapy : CK(257) : AC(38)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Neurotoxic : CK(1076) : AC(179)

Tamoxifen and Arimidex (anastrozole) can have detrimental effects on higher brain funtions.

Click here to read the entire abstract

Pubmed Data : J Clin Exp Neuropsychol. 2010 Mar 24:1-11. Epub 2010 Mar 24. PMID: 20336566

Article Published Date : Mar 24, 2010

Study Type : Human Study

Additional Links

Diseases : Breast Cancer : CK(2361) : AC(621), Cognitive Decline/Dysfunction : CK(522) : AC(87)

Problem Substances : Arimidex : CK(122) : AC(12), Tamoxifen : CK(319) : AC(39)

Tamoxifen and raloxifene adversely affect cognitive function in older women.

Click here to read the entire abstract

Pubmed Data : J Womens Health (Larchmt). 2010 Mar ;19(3):371-9. PMID: 20136553

Article Published Date : Mar 01, 2010

Study Type : Human Study

Additional Links

Diseases : Cognitive Decline/Dysfunction : CK(522) : AC(87)

Anti Therapeutic Actions : Chemotherapy : CK(257) : AC(38)

Problem Substances : Raloxifene : CK(103) : AC(11), Tamoxifen : CK(319) : AC(39)

Tamoxifen causes DNA adducs in the endometrium of women.

Click here to read the entire abstract

Pubmed Data : Carcinogenesis. 2000 Aug;21(8):1461-7. PMID: 10910945

Article Published Date : Aug 01, 2000

Study Type : Human Study

Additional Links

Diseases : Endometrial Cancer : CK(269) : AC(45), Endometrial Neoplasms : CK(41) : AC(5)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Carcinogenic : CK(912) : AC(117), Genotoxic : CK(146) : AC(61), Mutagenic : CK(22) : AC(11)

Tamoxifen has been shown to cause endometrial cancer in humans.

Click here to read the entire abstract

Pubmed Data : Eur J Obstet Gynecol Reprod Biol. 2001 Mar;95(1):105-10. PMID: 11267730

Article Published Date : Mar 01, 2001

Study Type : Human Study

Additional Links

Diseases : Breast Cancer : CK(2361) : AC(621), Endometrial Cancer : CK(269) : AC(45)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Carcinogenic : CK(912) : AC(117)

Tamoxifen increases the risk of endometrial hyperplasia and carcinoma in breast cancer patients.

Click here to read the entire abstract

Pubmed Data : Vopr Onkol. 2003;49(2):198-204. PMID: 12785205

Article Published Date : Jan 01, 2003

Study Type : Human Study

Additional Links

Diseases : Endometrial Cancer : CK(269) : AC(45)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Carcinogenic : CK(912) : AC(117)

Tamoxifen may induce fatty liver in patients with breast cancer.

Click here to read the entire abstract

Pubmed Data : AJR Am J Roentgenol. 2003 Jan;180(1):129-34. PMID: 12490491

Article Published Date : Jan 01, 2003

Study Type : Human Study

Additional Links

Diseases : Fatty Liver : CK(493) : AC(122)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Hepatotoxic : CK(283) : AC(80)

Tamoxifen therapy has been associated with the development of acute myeloid leukemia during breast cancer treatment.

Click here to read the entire abstract

Pubmed Data : Med Oncol. 1997 Mar;14(1):61-2. PMID: 9232614

Article Published Date : Mar 01, 1997

Study Type : Human Study

Additional Links

Diseases : Breast Cancer : CK(2361) : AC(621), Leukemia: Acute myelogenous leukemia (AML) : CK(96) : AC(28)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Carcinogenic : CK(912) : AC(117)

Tamoxifen treatment for breast cancer in Japanese women results in an increased risk for endomentrial and stomach cancer.

Click here to read the entire abstract

Pubmed Data : Ann Oncol. 2000 Dec;11(12):1537-43. PMID: 11205460

Article Published Date : Dec 01, 2000

Study Type : Human Study

Additional Links

Diseases : Breast Cancer : CK(2361) : AC(621), Endometrial Cancer : CK(269) : AC(45), Gastric Cancer : CK(373) : AC(111)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Carcinogenic : CK(912) : AC(117)

Tamoxifen treatment for breast cancer may result in fatty liver.

Click here to read the entire abstract

Pubmed Data : Oncol Rep. 2000 Nov-Dec;7(6):1299-304. PMID: 11032933

Article Published Date : Nov 01, 2000

Study Type : Human Study

Additional Links

Diseases : Chemically-Induced Liver Damage : CK(475) : AC(175), Fatty Liver : CK(493) : AC(122)

Additional Keywords : Drug: 5-flourouracil : CK(88) : AC(22), Drug: Doxorubicin : CK(141) : AC(55), Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Hepatotoxic : CK(283) : AC(80)

Tamoxifen treatment for breast cancer results in one-third of all patients developing endometrial polyps, hyperplasia, metaplasia, consistent with an estrogen-agonist effect.

Click here to read the entire abstract

Pubmed Data : Gynecol Oncol. 2000 Aug;78(2):181-6. PMID: 10926800

Article Published Date : Aug 01, 2000

Study Type : Human Study

Additional Links

Diseases : Breast Cancer : CK(2361) : AC(621), Endometrial Cancer : CK(269) : AC(45), Endometrial Neoplasms : CK(41) : AC(5)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Estrogen Agonist : CK(13) : AC(4), Estrogenic : CK(59) : AC(12)

Tamoxifen treatment in breast cancer may induce non-alcoholic fatty liver.

Click here to read the entire abstract

Pubmed Data : Intern Med. 2002 May;41(5):345-50. PMID: 12058881

Article Published Date : May 01, 2002

Study Type : Human Study

Additional Links

Diseases : Fatty Liver : CK(493) : AC(122)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Hepatotoxic : CK(283) : AC(80)

Tamoxifen treatment increases the risk of endometrial cancer in both premenopausal and postmenopausal women

Click here to read the entire abstract

Pubmed Data : J Natl Cancer Inst. 2005 Mar 2;97(5):375-84. PMID: 15741574

Article Published Date : Mar 02, 2005

Study Type : Human Study

Additional Links

Diseases : Breast Cancer : CK(2361) : AC(621), Endometrial Cancer : CK(269) : AC(45)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Carcinogenic : CK(912) : AC(117)

Tamoxifen treatment results in adverse structural and functional changes in the brain in women.

Click here to read the entire abstract

Pubmed Data : Neuroimage. 2004 Jan;21(1):364-71. PMID: 14741674

Article Published Date : Jan 01, 2004

Study Type : Human Study

Additional Links

Diseases : Drug-Induced Toxicity : CK(560) : AC(78), Memory Disorders: Drug-Induced : CK(77) : AC(12)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Neurotoxic : CK(1076) : AC(179)

Tamoxifen usage is associated with bone loss in patients who continued to menstruate after adjuvant chemotherapy.

Click here to read the entire abstract

Pubmed Data : J Clin Oncol. 2006 Feb 1;24(4):675-80. PMID: 16446340

Article Published Date : Feb 01, 2006

Study Type : Human Study

Additional Links

Diseases : Osteoporosis : CK(1171) : AC(205)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Tamoxifen use is associated with increased risk for endomentrial polyps and cancer.

Click here to read the entire abstract

Pubmed Data : Gynecol Obstet Fertil. 2005 Dec;33(12):975-9. PMID: 16321556

Article Published Date : Dec 01, 2005

Study Type : Human Study

Additional Links

Diseases : Breast Cancer : CK(2361) : AC(621), Endometrial Cancer : CK(269) : AC(45), Endometrial Neoplasms : CK(41) : AC(5)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Carcinogen : CK(59) : AC(11)

The widespread use of tamoxifen as a preventive agent against breast cancer in healthy women may result in significantly elevated levels of endometrial cancer.

Click here to read the entire abstract

Pubmed Data : Lancet. 2000 Sep 9;356(9233):881-7. PMID: 11036892

Article Published Date : Sep 09, 2000

Study Type : Human Study

Additional Links

Diseases : Breast Cancer : CK(2361) : AC(621), Endometrial Cancer : CK(269) : AC(45)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Adverse Pharmacological Actions : Carcinogenic : CK(912) : AC(117)

Women treated with tamoxifen in the adjuvant setting experienced symptoms of sexual dysfunction.

Click here to read the entire abstract

Pubmed Data : J Clin Oncol. 1999 May;17(5):1488-92. PMID: 10334535

Article Published Date : May 01, 1999

Study Type : Human Study

Additional Links

Diseases : Drug-Induced Toxicity : CK(560) : AC(78), Sexual Dysfunction : CK(74) : AC(13)

Additional Keywords : Drug: Tamoxifen : CK(380) : AC(57)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Sesame seeds should be avoided during Tamoxifen therapy.

Click here to read the entire abstract

Pubmed Data : Exp Biol Med (Maywood). 2007 Jun;232(6):754-61. PMID: 17526767

Article Published Date : Jun 01, 2007

Study Type : Animal Study

Additional Links

Substances : Sesame Seeds : CK(151) : AC(27)

Diseases : Breast Cancer: Conventional Treatment : CK(14) : AC(1)

Additional Keywords : Drug/Natural Substance Contraindications : CK(3) : AC(2)

Problem Substances : Tamoxifen : CK(319) : AC(39)

Health Guide: Cancer Research

Related Blogs

Movember: Count Me Out

Written by Dr. B.J. Hardick, D.C.

Every November, we see pictures of hairy male faces all over the media. The more outrageous the facial hair, the better! It feels like a throwback to the 1970's, for those of us that can remember that far back. But my face won't be one of the hairy ones. It's my own personal objection to the tragedy of "Movember."

Seaweed versus Chemotherapy: Can Seaweed Treat Cancer?

Written by Case Adams, Naturopath

Several recent international studies have illustrated that seaweeds and their extracts may have the capability of inhibiting and even treating cancer. Seaweed therapy may even outperform chemotherapy.

The Dark Side of Breast Cancer (Un)Awareness Month

Written by Sayer Ji, Founder

Sadly, Breast Cancer Awareness Month is a time of increasing awareness not of the preventable causes of breast cancer, but of the breast cancer industry's insatiable need to both raise money for research into a pharmaceutical cure, and to promote its primary means of "prevention": early detection via x-ray mammography.

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Printer-friendly version
Send to friend
PDF version